[CYCC] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
15-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 19.22%
YoY- 35.59%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Revenue 512 396 212 161 192 271 228 14.42%
PBT -5,675 -5,446 -3,356 -3,123 -4,779 -5,244 -5,421 0.76%
Tax -763 -569 -258 -168 -191 -133 -358 13.43%
NP -4,912 -4,869 -3,082 -2,955 -4,588 -5,111 -5,063 -0.50%
Tax Rate - - - - - - - -
Total Cost 5,424 5,265 3,294 3,116 4,780 5,382 5,291 0.41%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
NP Margin -959.38 -1,229.55 -1,453.77 -1,835.40 -2,389.58 -1,885.98 -2,220.61 -13.04%
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
EPS -45.23 -59.83 -75.55 -90.66 -165.51 -270.70 -416.30 -30.91%
EPS Diluted -45.23 -59.83 -75.55 -90.66 -165.51 -270.70 -416.30 -30.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.